Boston Scientific Lowers Full-Year Targets After Cyberattack -- WSJ

By Alex Janin

Medical-device maker Boston Scientific said that it is unlikely to meet its sales growth and earnings expectations for the year, citing a major cyberattack disclosed last month that left it unable to fill orders. Boston Scientific's shares fell more than 4% Tuesday morning and are now down 52% from a year earlier. The company said the cyberattack affected manufacturing and the full impact isn't yet known.

Analysts didn't think the attack would likely lead to long-term loss of market share.

"Some of the cyber security incidents have been resolved with relatively low incidence" in the med-tech industry, Citi analyst Joanne Wuensch wrote shortly after the incident.

This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage).

(END) Dow Jones Newswires

September 08, 2026 11:43 ET (15:43 GMT)